A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Magnesium cation
Cirazoline
The therapeutic efficacy of Cirazoline can be decreased when used in combination with Niguldipine.
Magnesium cation
Tetryzoline
The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Niguldipine.
Magnesium cation
Isometheptene
The therapeutic efficacy of Isometheptene can be decreased when used in combination with Niguldipine.
Magnesium cation
Phendimetrazine
The therapeutic efficacy of Phendimetrazine can be decreased when used in combination with Niguldipine.
Magnesium cation
4-Methoxyamphetamine
The therapeutic efficacy of 4-Methoxyamphetamine can be decreased when used in combination with Niguldipine.
Magnesium cation
Macimorelin
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Macimorelin.
Magnesium cation
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Deutetrabenazine.
Magnesium cation
Glasdegib
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Glasdegib.
Magnesium cation
Ribociclib
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Ribociclib.
Magnesium cation
Lumefantrine
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Lumefantrine.
Magnesium cation
Artemether
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Artemether.
Magnesium cation
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Tetrabenazine.
Magnesium cation
Temafloxacin
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Temafloxacin.
Magnesium cation
Tofacitinib
Tofacitinib may increase the bradycardic activities of Niguldipine.
Magnesium cation
Lacosamide
Lacosamide may increase the bradycardic activities of Niguldipine.
Magnesium cation
Poractant alfa
Poractant alfa may increase the bradycardic activities of Niguldipine.
Magnesium cation
Lanreotide
Lanreotide may increase the bradycardic activities of Niguldipine.
Magnesium cation
Beractant
Beractant may increase the bradycardic activities of Niguldipine.
Magnesium cation
Calfactant
Calfactant may increase the bradycardic activities of Niguldipine.
Magnesium cation
Lucinactant
Lucinactant may increase the bradycardic activities of Niguldipine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3